Loading...

Advertisement

Alpine Immune Sciences Appoints Wolfgang Dummer To Succeed Andrew Sandler As Chief Medical Officer

RTTNews | 644 days ago

Alpine Immune Sciences Appoints Wolfgang Dummer To Succeed Andrew Sandler As Chief Medical Officer

(RTTNews) - Alpine Immune Sciences, Inc. (ALPN), a clinical-stage immunotherapy company, announced Wednesday the appointment of Wolfgang Dummer, M.D., Ph.D., to Chief Medical Officer effective October 2, 2023.

Dummer succeeds Andrew Sandler, M.D., who will transition responsibilities to Dummer through the remainder of the year.

Dummer brings over 20 years of global drug development leadership experience and has led the development of multiple drug approvals in immunology and rare diseases. He joins Alpine from Rigel Pharmaceuticals, where he served as Chief Medical Officer.

Prior to his time at Rigel, Dummer served as Vice President of Clinical Development at BioMarin, and previously held various roles of increasing responsibility at Genentech where he was Global Development Leader for ocrelizumab and rituximab.

In conjunction with his employment, effective October 2, 2023, Dummer has been granted an option to purchase 200,000 shares of common stock.

Tags: ALPN

read more

Bay Street May Open On Positive Note

Bay Street May Open On Positive Note

Slightly higher Canadian and U.S. futures point to a marginally positive start for Canadian shares on Wednesday. The focus will be on trade deal negotiations.

RTTNews | 4 minutes ago

Yen Falls As Traders Speculate BoJ Rate Hike Pause

Yen Falls As Traders Speculate BoJ Rate Hike Pause

The Japanese yen weakened against other major currencies in the late Asian session on Wednesday, as traders reduced their bets on an immediate interest rate hike by the Bank of Japan (BoJ) due to worries about the possible economic effects of US President Donald Trump's trade tariffs.

RTTNews | 1h 0min ago

Malaysia Central Bank Cuts Policy Rate For First Time Since 2020

Malaysia Central Bank Cuts Policy Rate For First Time Since 2020

Malaysia's central bank lowered its key interest rate for the first time in five years on Wednesday to underpin economic growth amid the ongoing trade tariff uncertainty. The Monetary Policy Committee of Bank Negara Malaysia decided to reduce the Overnight Policy Rate by 25 basis points to 2.75 percent. The ceiling and floor rates of the corridor of the OPR were correspondingly reduced.

RTTNews | 1h 0min ago

FTSE 100 Modestly Higher

FTSE 100 Modestly Higher

The UK market remains firmly placed in positive territory a little past noon on Wednesday, holding gains after a steady start, amid rising optimism about the European Union striking a deal with the U.S. in the coming weeks.

RTTNews | 1h 18min ago

CAC 40 Up 1.25% On Trade Deal Optimism

CAC 40 Up 1.25% On Trade Deal Optimism

French stocks are up in positive territory on Wednesday, extending gains to a third straight session, amid optimism about U.S. and the European Union striking a deal sometime soon, despite U.S. President Donald Trump's threat that steep tariffs will be imposed on copper imports, and pharmaceuticals.

RTTNews | 1h 42min ago

DAX Rises Sharply On US-EU Trade Deal Hopes

DAX Rises Sharply On US-EU Trade Deal Hopes

German stocks climbed up on Wednesday, lifting the benchmark DAX to a one-month high, as expectations of a US-European Union deal helped underpin sentiment.

RTTNews | 1h 56min ago

Sensex Drops 176 Points On Tariff Uncertainty; Nifty Dips Below 25,500

Sensex Drops 176 Points On Tariff Uncertainty; Nifty Dips Below 25,500

Indian shares fell modestly on Wednesday as uncertainty prevailed over U.S. President Donald Trump's tariff plans.

RTTNews | 2h 38min ago

NZ Dollar Falls After RBNZ Rate Decision

NZ Dollar Falls After RBNZ Rate Decision

The New Zealand dollar retreated from recent highs against other major currencies in the Asian session on Wednesday, after the Reserve Bank of New Zealand's (RBNZ) widely anticipated decision to maintain rates constant.

RTTNews | 3h 38min ago

Terms | Privacy | Site Map | Site Map Calendar

© 2025 Myfxbook Ltd. All Rights Reserved.

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.